These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12237532)

  • 1. Mass variation tests for coating tablets and hard capsules: rational application of mass variation tests.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1176-80. PubMed ID: 12237532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of the applicability of content uniformity and weight variation test--the state of commercial tablets and capsules in Japan.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1412-9. PubMed ID: 11724231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements.
    Moes JJ; Ruijken MM; Gout E; Frijlink HW; Ugwoke MI
    Int J Pharm; 2008 Jun; 357(1-2):108-18. PubMed ID: 18394831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid at-line analysis of coating thickness and uniformity on tablets using laser induced breakdown spectroscopy.
    Mowery MD; Sing R; Kirsch J; Razaghi A; Béchard S; Reed RA
    J Pharm Biomed Anal; 2002 Jun; 28(5):935-43. PubMed ID: 12039636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of pan coating processes: Prediction of tablet content uniformity and determination of critical process parameters.
    Chen W; Chang SY; Kiang S; Marchut A; Lyngberg O; Wang J; Rao V; Desai D; Stamato H; Early W
    J Pharm Sci; 2010 Jul; 99(7):3213-25. PubMed ID: 20091834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle size limits to meet USP content uniformity criteria for tablets and capsules.
    Rohrs BR; Amidon GE; Meury RH; Secreast PJ; King HM; Skoug CJ
    J Pharm Sci; 2006 May; 95(5):1049-59. PubMed ID: 16552749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
    Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M
    PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of recent advances in continuous film coating processes.
    Cunningham C; Hansell J; Nuneviller F; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):227-33. PubMed ID: 19954403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric coating of soft gelatin capsules by spouted bed: effect of operating conditions on coating efficiency and on product quality.
    Pissinati R; Oliveira WP
    Eur J Pharm Biopharm; 2003 May; 55(3):313-21. PubMed ID: 12754006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of formulation variables on weight uniformity of scored tablets using factorial design.
    Zaid AN; Hawari R; Malkieh N; Natshih Y; Yousef A; Jaradat N; Hammad A; Basharat R
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2501-2507. PubMed ID: 31894042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Raman spectroscopy as PAT tool in active coating.
    Müller J; Knop K; Thies J; Uerpmann C; Kleinebudde P
    Drug Dev Ind Pharm; 2010 Feb; 36(2):234-43. PubMed ID: 19778159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of tablet coating uniformity using a quality by design approach.
    Dubey A; Boukouvala F; Keyvan G; Hsia R; Saranteas K; Brone D; Misra T; Ierapetritou MG; Muzzio FJ
    AAPS PharmSciTech; 2012 Mar; 13(1):231-46. PubMed ID: 22232020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three pharmaceutical products obtained from Mexico and the United States: a case study.
    Karlage KL; Myrdal PB
    Drug Dev Ind Pharm; 2005 Dec; 31(10):993-1000. PubMed ID: 16316855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers.
    Petereit HU; Weisbrod W
    Eur J Pharm Biopharm; 1999 Jan; 47(1):15-25. PubMed ID: 10234523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tablet-to-tablet variation of drug content of sugar-coated tablets containing drug in the sugar coat.
    Carstensen JT; Koff A; Johnson JB; Rubin SH
    J Pharm Sci; 1970 Apr; 59(4):553-5. PubMed ID: 5440688
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
    Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
    Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.